Back to news

Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors

Business Wire•18/11/2026•16:01 ET
0

Key Highlights

  • ➤Paul J. Clancy joins Align Technology’s board effective immediately.
  • ➤Ian Bell joins Align Technology’s board effective December 10, 2026.
  • ➤Align’s board will have 13 directors until C. Raymond Larkin’s December 31, 2026 retirement.
  • ➤Clancy and Bell will appear in Align’s director slate for the 2027 annual meeting.

Expert Statements

Kevin Conroy, Chairman of the Board of Align Technology

“We are pleased to welcome Paul Clancy to our Board and look forward to the addition of Ian Bell in December,”

Kevin Conroy, Chairman of the Board of Align Technology

“Paul and Ian bring significant global healthcare, financial, innovation and operational leadership experience that will complement the strengths of Align’s Board.”

Kevin Conroy, Chairman of the Board of Align Technology

“Paul’s deep financial and strategic leadership in the biopharmaceutical industry, together with Ian’s broad perspective across commercial, manufacturing, quality and regulatory operations and his experience leading innovation-driven businesses, will be valuable as we continue to execute our strategy and drive long-term growth.”

Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors

Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign(® )System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has appointed Paul J. Clancy, a biopharmaceutical executive and former Executive Vice President and Chief Financial Officer of Alexion Pharmaceuticals, Inc. and Biogen Inc., as a director effective immediately and Ian Bell, Senior Vice President and Chief Operating Officer of Alcon Inc., as a director effective December 10, 2026.

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in